Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup

We compared the perioperative and postoperative characteristics of prostate PlasmaKinetic™ enucleation and bipolar transurethral resection for large volume benign prostatic hyperplasia. In this prospective, randomized, controlled trial 80 patients with benign prostatic hyperplasia and a prostate of...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of urology Vol. 189; no. 4; p. 1427
Main Authors: Zhu, Lingfeng, Chen, Shushang, Yang, Shunliang, Wu, Meijing, Ge, Rong, Wu, Weizhen, Liao, Lianming, Tan, Jianming
Format: Journal Article
Language:English
Published: United States 01-04-2013
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract We compared the perioperative and postoperative characteristics of prostate PlasmaKinetic™ enucleation and bipolar transurethral resection for large volume benign prostatic hyperplasia. In this prospective, randomized, controlled trial 80 patients with benign prostatic hyperplasia and a prostate of larger than 70 ml were randomly assigned to prostate bipolar transurethral resection or PlasmaKinetic enucleation. Operative time, resected adenoma weight, changes in hemoglobin, catheterization time and postoperative hospital stay were recorded and compared. Patients were followed 1, 6, 12, 24, 36, 48 and 60 months after surgery. Greater resected prostate weight (mean ± SD 64.2 ± 19.0 vs 50.6 ± 20.0 gm, p = 0.03), less blood loss (mean 0.87 ± 0.42 vs 1.74 ± 0.63 gm, p <0.01), and shorter catheterization time (mean 35.5 ± 5.8 vs 60.1 ± 5.8 hours, p <0.01) and postoperative hospital stay (mean 3 vs 4 days, [corrected] p <0.01) were recorded in the enucleation group than in the resection group. The postoperative improvement in International Prostate Symptom Score, quality of life, maximal flow rate and post-void residual urine volume was similar in the 2 groups at 1, 6, 12 and 24 months but significantly better in the enucleation group at 36, 48 and 60 months. During the 5-year followup no patient in the enucleation group but 2 in the resection group experienced recurrence. For large volume benign prostatic hyperplasia PlasmaKinetic enucleation of the prostate is associated with less blood loss, shorter hospital stay and catheterization time than bipolar transurethral resection of the prostate. Moreover, PlasmaKinetic enucleation seems to be superior at long-term followup with fewer reoperations necessary.
AbstractList We compared the perioperative and postoperative characteristics of prostate PlasmaKinetic™ enucleation and bipolar transurethral resection for large volume benign prostatic hyperplasia. In this prospective, randomized, controlled trial 80 patients with benign prostatic hyperplasia and a prostate of larger than 70 ml were randomly assigned to prostate bipolar transurethral resection or PlasmaKinetic enucleation. Operative time, resected adenoma weight, changes in hemoglobin, catheterization time and postoperative hospital stay were recorded and compared. Patients were followed 1, 6, 12, 24, 36, 48 and 60 months after surgery. Greater resected prostate weight (mean ± SD 64.2 ± 19.0 vs 50.6 ± 20.0 gm, p = 0.03), less blood loss (mean 0.87 ± 0.42 vs 1.74 ± 0.63 gm, p <0.01), and shorter catheterization time (mean 35.5 ± 5.8 vs 60.1 ± 5.8 hours, p <0.01) and postoperative hospital stay (mean 3 vs 4 days, [corrected] p <0.01) were recorded in the enucleation group than in the resection group. The postoperative improvement in International Prostate Symptom Score, quality of life, maximal flow rate and post-void residual urine volume was similar in the 2 groups at 1, 6, 12 and 24 months but significantly better in the enucleation group at 36, 48 and 60 months. During the 5-year followup no patient in the enucleation group but 2 in the resection group experienced recurrence. For large volume benign prostatic hyperplasia PlasmaKinetic enucleation of the prostate is associated with less blood loss, shorter hospital stay and catheterization time than bipolar transurethral resection of the prostate. Moreover, PlasmaKinetic enucleation seems to be superior at long-term followup with fewer reoperations necessary.
Author Chen, Shushang
Wu, Meijing
Liao, Lianming
Yang, Shunliang
Wu, Weizhen
Tan, Jianming
Zhu, Lingfeng
Ge, Rong
Author_xml – sequence: 1
  givenname: Lingfeng
  surname: Zhu
  fullname: Zhu, Lingfeng
  organization: Department of Urology, Fuzhou General Hospital, Xiamen University, Fujian Medical University, Fuzhou, Fujian, People's Republic of China
– sequence: 2
  givenname: Shushang
  surname: Chen
  fullname: Chen, Shushang
– sequence: 3
  givenname: Shunliang
  surname: Yang
  fullname: Yang, Shunliang
– sequence: 4
  givenname: Meijing
  surname: Wu
  fullname: Wu, Meijing
– sequence: 5
  givenname: Rong
  surname: Ge
  fullname: Ge, Rong
– sequence: 6
  givenname: Weizhen
  surname: Wu
  fullname: Wu, Weizhen
– sequence: 7
  givenname: Lianming
  surname: Liao
  fullname: Liao, Lianming
– sequence: 8
  givenname: Jianming
  surname: Tan
  fullname: Tan, Jianming
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23123549$$D View this record in MEDLINE/PubMed
BookMark eNo1kMtOwzAQRS0Eog_4ARbIH0CC7dhxwg5V5SFVYgPrykkmTSonjmynVfkSPheHx2qkmXPPSHeBznvTA0I3lMSU0PR-H-9Ha2JGKIunHZVnaE4Fk1EiczZDC-f2hFAuJLtEM5ZQlgiez9HXWkPprXGj3bWl0hj6sdSgfGt6fADrRoeLdjBaWeyt6gMHvrEBtOBCcsJqY_EQFF55cDiQOwhwo3osCe70A1Y_52HCD3CHg6YyXfsJVVC2QXVsfYNFdILwpDZam-M4XKGLWmkH139ziT6e1u-rl2jz9vy6etxEJefURwkhQqS1THkGORBVi1qqLGOUS65kkVV1kpZVnvKE8oIwwgWnquKETQUAAbZEt7_eYSw6qLaDbTtlT9v_itg38M5sxw
CitedBy_id crossref_primary_10_1016_j_ajur_2017_11_001
crossref_primary_10_1016_j_urology_2016_12_024
crossref_primary_10_1089_end_2013_0374
crossref_primary_10_1097_MD_0000000000013897
crossref_primary_10_21886_2308_6424_2023_11_4_128_140
crossref_primary_10_1038_srep14542
crossref_primary_10_1016_j_kjms_2018_03_001
crossref_primary_10_1007_s00345_017_2034_4
crossref_primary_10_1016_S0120_789X_14_50054_8
crossref_primary_10_1038_s41391_019_0135_4
crossref_primary_10_1016_j_ajur_2017_12_001
crossref_primary_10_1007_s00345_017_2071_z
crossref_primary_10_1111_and_13612
crossref_primary_10_1016_j_eururo_2014_06_017
crossref_primary_10_1089_end_2017_0489
crossref_primary_10_1007_s00120_019_0891_8
crossref_primary_10_1007_s11255_014_0786_y
crossref_primary_10_1371_journal_pone_0253083
crossref_primary_10_1007_s00345_023_04666_8
crossref_primary_10_1007_s00345_020_03382_x
crossref_primary_10_1016_j_acuro_2015_05_010
crossref_primary_10_1097_MD_0000000000003862
crossref_primary_10_1007_s00120_016_0245_8
crossref_primary_10_1007_s11884_015_0294_7
crossref_primary_10_1016_j_urology_2019_07_029
crossref_primary_10_1089_end_2019_0707
crossref_primary_10_1097_MOU_0000000000000244
crossref_primary_10_1097_MOU_0000000000000125
crossref_primary_10_1016_j_aju_2016_02_003
crossref_primary_10_1016_j_eururo_2021_04_012
crossref_primary_10_1007_s00345_022_03946_z
crossref_primary_10_1111_iju_13401
crossref_primary_10_1007_s40266_023_01054_0
crossref_primary_10_1590_s1677_5538_ibju_2016_0237
crossref_primary_10_1007_s00345_024_04865_x
crossref_primary_10_1007_s00345_017_2158_6
crossref_primary_10_1155_2020_8241637
crossref_primary_10_1089_end_2019_0630
crossref_primary_10_1007_s00345_021_03705_6
crossref_primary_10_1007_s00345_018_2321_8
crossref_primary_10_1111_luts_12189
crossref_primary_10_1016_j_acuroe_2015_11_007
crossref_primary_10_1007_s00345_013_1210_4
crossref_primary_10_1089_end_2022_0685
crossref_primary_10_1097_MD_0000000000013360
crossref_primary_10_1007_s10103_019_02760_1
crossref_primary_10_1159_000348793
crossref_primary_10_1007_s10103_013_1437_8
crossref_primary_10_1007_s00345_019_02968_4
crossref_primary_10_1016_j_eururo_2023_04_008
crossref_primary_10_1016_j_purol_2020_12_006
crossref_primary_10_1080_08998280_2022_2116764
crossref_primary_10_1007_s00345_019_02890_9
crossref_primary_10_1007_s11884_023_00687_6
crossref_primary_10_3390_jcm9051412
crossref_primary_10_1007_s00120_019_0910_9
crossref_primary_10_1007_s00345_021_03718_1
crossref_primary_10_1007_s00120_014_3652_8
crossref_primary_10_2147_RRU_S280113
crossref_primary_10_1111_bju_15161
crossref_primary_10_1089_end_2018_0700
crossref_primary_10_1089_end_2020_0141
crossref_primary_10_1111_and_13724
crossref_primary_10_1016_j_eururo_2014_01_010
crossref_primary_10_1089_end_2015_0867
crossref_primary_10_1089_end_2014_0493
ContentType Journal Article
Copyright Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1016/j.juro.2012.10.117
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1527-3792
ExternalDocumentID 23123549
Genre Randomized Controlled Trial
Journal Article
GroupedDBID ---
--K
.55
.GJ
.XZ
08P
0R~
123
1B1
1CY
354
3O-
4.4
457
4G.
4Q1
4Q2
4Q3
53G
5RE
5VS
7-5
AAAAV
AAEDT
AAEDW
AAGIX
AAHPQ
AAIQE
AAJCS
AAKAS
AALRI
AAMOA
AAQFI
AAQKA
AAQQT
AAQXK
AASCR
AASXQ
AAXUO
ABASU
ABCQX
ABDIG
ABJNI
ABLJU
ABMAC
ABOCM
ABPPZ
ABVCZ
ACGFS
ACILI
ACLDA
ACOAL
ACXJB
ADGGA
ADHPY
ADMUD
ADNKB
ADPAM
ADZCM
AEBDS
AEETU
AENEX
AFDTB
AFEXH
AFFNX
AFTRI
AFUWQ
AGHFR
AHOMT
AHQNM
AHRYX
AHVBC
AI.
AINUH
AITUG
AIZYK
AJIOK
AJNWD
AJZMW
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AMRAJ
ASGHL
ASPBG
AVWKF
AZFZN
BCGUY
BELOY
BYPQX
C45
C5W
CGR
CS3
CUY
CVF
DIWNM
DU5
EBS
ECM
EEVPB
EIF
EJD
ERAAH
EX3
F5P
FCALG
FDB
FEDTE
FGOYB
GBLVA
GNXGY
GQDEL
HLJTE
HVGLF
HZ~
H~9
IH2
IHE
IKREB
IKYAY
IPNFZ
J5H
KMI
L7B
M41
MJL
MO0
N4W
NPM
NQ-
NTWIH
O9-
OAG
OAH
OB3
OBH
ODMTH
OGROG
OHH
OL1
OVD
OWU
OWV
OWW
OWY
OWZ
P2P
QTD
R2-
RIG
RLZ
ROL
RPZ
SEL
SES
SJN
SSZ
TEORI
TSPGW
UDS
UNMZH
UV1
VH1
VVN
WOW
X7M
XH2
XYM
YFH
YOC
ZCG
ZFV
ZGI
ZXP
ZY1
ZZMQN
ID FETCH-LOGICAL-c441t-300556f7648e9e0af5f7a8821474a7b8df36cd964314b0204541ad4021235e0e2
IngestDate Tue Oct 15 23:50:14 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c441t-300556f7648e9e0af5f7a8821474a7b8df36cd964314b0204541ad4021235e0e2
PMID 23123549
ParticipantIDs pubmed_primary_23123549
PublicationCentury 2000
PublicationDate 2013-04-01
PublicationDateYYYYMMDD 2013-04-01
PublicationDate_xml – month: 04
  year: 2013
  text: 2013-04-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of urology
PublicationTitleAlternate J Urol
PublicationYear 2013
References J Urol. 2013 Jun;189(6):2396
References_xml
SSID ssj0014572
Score 2.4193153
Snippet We compared the perioperative and postoperative characteristics of prostate PlasmaKinetic™ enucleation and bipolar transurethral resection for large volume...
SourceID pubmed
SourceType Index Database
StartPage 1427
SubjectTerms Electrosurgery
Follow-Up Studies
Humans
Male
Middle Aged
Organ Size
Prospective Studies
Prostate - pathology
Prostatectomy - methods
Prostatic Hyperplasia - pathology
Prostatic Hyperplasia - surgery
Time Factors
Transurethral Resection of Prostate - methods
Title Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup
URI https://www.ncbi.nlm.nih.gov/pubmed/23123549
Volume 189
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nj9MwELVakBAXxDcsH5oDt5JVk9pxsje0FO2lXHYRiMsqiW3aqk2rZiO0-0v25-6M7aTZIBAcuERRHFmt5-l5PJl5w9g79DlEEfMsKLicBDzOeZBrvCtUmigZizSzugUnp_Lzt-TjlE8Hg6Zxwf7Zf7U0PkNbU-XsP1i7nRQf4D3aHK9odbz-ld2nrq9NVe8cp-mSFIudmSkFo65G-WJLB1pqD1FSgPBivrPy_pUu2szDLVWDkB86WlGuOKUiIhPI8Wi9cvXR9IKv0iQz4VRqs15cof_qGoHYAK8ILkkoyCDYNj99jGu5x2fHG653t-L73-e1jxj8MNpvrjYJwbHk6byuKNLdclYT9Z7XJcVt2oGvdpqZXiybLdpHOKjbRJsYoz0rR8SEaY-20w4-eYeEQ-7kBn7ZHVygYnm4xP9EWX3Roftq3X0Z13C7tthAzzeaCCeo-ufRnmJ3MzRkQ_S_yEU_nrVftriQkS_ecnmG_R9D8tR-gt5Rx7o8Zw_ZA28d-OBA9ogNdPmY3Zv5bIwn7LqHNehgDRzWwGMNbmENWqwBYg1arIHDGhDWQI5hvTqCDDpIew97nIHFGRDOwOEMGpw9ZV8-Tc-OTwLf6QMpgocXAfVMELGRMU90qseZEUZmePYLueSZzBNlJjGyB3rPIc-pnFvwMFOc2hNMhB7r6Bm7U25K_YJBkak4Qc-PZNK40mlemDCOI6V4aJCX5Ev23K3p-dbJuZw3q33w25FX7P4el6_ZXYNcod-wYaXqt9a6N6DikNw
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Electrosurgical+enucleation+versus+bipolar+transurethral+resection+for+prostates+larger+than+70+ml%3A+a+prospective%2C+randomized+trial+with+5-year+followup&rft.jtitle=The+Journal+of+urology&rft.au=Zhu%2C+Lingfeng&rft.au=Chen%2C+Shushang&rft.au=Yang%2C+Shunliang&rft.au=Wu%2C+Meijing&rft.date=2013-04-01&rft.eissn=1527-3792&rft.volume=189&rft.issue=4&rft.spage=1427&rft_id=info:doi/10.1016%2Fj.juro.2012.10.117&rft_id=info%3Apmid%2F23123549&rft_id=info%3Apmid%2F23123549&rft.externalDocID=23123549